SEARCH

SEARCH BY CITATION

Reference

  • 1
    Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA: The epidemiology of Wegener's granulomatosis: estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 39: 8792, 1996
  • 2
    Cotch MF, Hoffman GS: The prevalence, epidemiology and cost of hospitalizations for vasculitis in New York State: 1986 to 1990 (abstract). Arthritis Rheum 38 (suppl 9): S225, 1995
  • 3
    Walton EW: Giant cell granuloma of the respiratory tract (Wegener's granulomatosis). BMJ 2: 265270, 1958
  • 4
    Hollander D, Manning RT: The use of alkylating agents in the treatment of Wegener's granulomatosis. Ann Intern Med 67: 393398, 1967
  • 5
    Fauci AS, Wolff SM: Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) 52: 535561, 1973
  • 6
    Reza MJ, Dornfeld L, Goldberg LS, Bluestone R, Pearson CM: Wegener's granulomatosis: long-term followup of patients treated with cyclophosphamide. Arthritis Rheum 18: 501506, 1975
  • 7
    Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 7685, 1983
  • 8
    Brandwein S, Esdaile J, Danoff D, Tannenbaum H: Wegener's granulomatosis: clinical features and outcome in 13 patients. Arch Intern Med 143: 476479, 1983
  • 9
    Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 116: 488498, 1992
  • 10
    Hoffman GS: Wegener's granulomatosis: the path traveled since 1931. Medicine (Baltimore) 73: 325329, 1995
  • 11
    Richter C, Schnabel A, Cernok E, de Groot K, Reinhold-Keller E, Gross WL: Treatment of antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. Clin Exp Immunol 101: 27, 1995
  • 12
    Jayne DRW, Esnault VLM, Lockwood CM: ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. J Autoimmun 6: 207219, 1993
  • 13
    Hagen EC, de Keizer RJ, Andrassy K, van Boven WP, Bruijn JA, van Es LA, van der Woude FJ: Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin. Clin Nephrol 43: 351359, 1995
  • 14
    Hoffman GS, Leavitt RY, Kerr GS, Fauci AS: The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 35: 13221329, 1992
  • 15
    Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS: An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 38: 608613, 1995
  • 16
    Handrock K, Reinhold-Keller E, Heller M, Duncker G, Rudert H, Gross WL: Beneficial effects of low-dose methotrexate in Wegener's granulomatosis (abstract). Arthritis Rheum 37 (suppl 9): S353, 1994
  • 17
    Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, Sneller MC: Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Intern Med 124: 477484, 1996
  • 18
    Moder KG, Tefferi A, Cohen MD, Menke DM, Luthra HS: Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am J Med 99: 276281, 1995
  • 19
    Kamel OW, van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF: Lymphoid neoplasm in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25: 638643, 1994
  • 20
    Kingsmore SF, Hall BD, Allen NB, Rice JR, Caldwell DS: Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review. J Rheumatol 19: 14621465, 1992
  • 21
    Liote F, Pertuiset E, Cochand-Priollet B, d'Agay MF, Dombret H, Numeric P, D'Anglejan G, Kuntz D: Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis: role of Epstein-Barr virus infection. J Rheumatol 22: 11741178, 1995
  • 22
    Kamel OW, van de Rijn M, Weiss LM, del Zoppo GJ, Hench PK, Robbins BA, Montgomery PG, Warnke RA, Dorfman RF: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328: 13171321, 1993
  • 23
    Shiroky JB, Newkirk MM: Reversible lymphomas (letter). N Engl J Med 329: 16571658, 1993
  • 24
    Alarcón GS, Lightfoot RW, Kremer JM, Weinblatt ME, Willkens RF, Williams HJ, Furst DE: Selective vs unselective liver biopsies in methotrexate-treated rheumatoid arthritis patients (abstract). Arthritis Rheum 36 (suppl 9): S64, 1993
  • 25
    Bergquist SR, Felson DT, Freedberg KA: The cost-effectiveness of liver biopsy in rheumatoid arthritis patients on methotrexate (abstract). Arthritis Rheum 36 (suppl 9): S63, 1993
  • 26
    El-Behery A, El Mansy E, Salama N: Methotrexate and fertility in men. Arch Androl 3: 177179, 1979
  • 27
    Sussman A, Leonard JM: Psoriasis, methotrexate, and oligospermia. Arch Dermatol 116: 215217, 1980
  • 28
    De Groot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Nölle B, Gross WL: Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis: methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 39: 20522061, 1996
  • 29
    Guillevin L, Cordier J-F, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson J-F, Détrée F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M: A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 40: 21872198, 1997
  • 30
    Huong Du LT, Papo T, Piette JC, Wechsler B, Bletry O, Lamas G, Baumelou A, Le Hoang P, Pennaforte JL, Valcke JC, Godeau P: Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis. Clin Exp Rheumatol 14: 916, 1996
  • 31
    Falk RJ, Hogan S, Carey TS, Jennette JC, The Glomerular Disease Collaborative Network: Clinical course of antineutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 113: 656663, 1990
  • 32
    Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, Michael J, Savage COS, Bacon PA: Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM 90: 401409, 1997
  • 33
    Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS: Treatment of Wegener's granulomatosis with intermittent high dose intravenous cyclophosphamide. Am J Med 89: 403410, 1990
  • 34
    Reinhold-Keller E, Kekow J, Schabel A, Schwarz-Eywill M, Schmitt WH, Gross WL: Effectiveness of cyclophosphamide pulse treatment in Wegener's granulomatosis. In, ANCA-Associated Vasculitides: Immunologic and Clinical Aspects. Edited by WLGross. New York, Plenum Press, 1993
  • 35
    Godeau B, Mainardi JL, Roudot-Thoraval F, Hachulla E, Guillevin L, Huong Du LT, Jarrousse B, Remy P, Schaeffer A, Piette JC: Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis. Ann Rheum Dis 54: 991994, 1995
  • 36
    Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS, Leavitt RY: Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 151: 795799, 1995